Lifevantage Corp (LFVN) FY2025 10-K Annual Report
Lifevantage Corp (LFVN) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Sep 4, 2025. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
Lifevantage Corp FY2025 10-K Analysis
Business Overview
- • Core business model: Direct sales of nutrigenomic-based dietary supplements and wellness products promoting health activation through genetic pathways
- • New product emphasis: Launched patent-pending MindBody GLP-1 System™ targeting gut-brain axis for appetite control and weight management
- • Strategic shift: Expanded and optimized Evolve Compensation Plan globally for independent consultants, enhancing recruitment and retention efforts
- • Quantitative metric: Rewards Circle loyalty program expanded to six new regions by February 2024, incentivizing subscription purchases among customers and consultants
- • Noteworthy fact: Introduced technology-driven consultant engagement tools using AI and machine learning to personalize sales guidance and improve productivity
Management Discussion & Analysis
- • Cash and equivalents $20.2M at June 30, 2025, up $3.3M from $16.9M at June 30, 2024
- • Net cash from operations $11.9M in FY2025 vs $12.2M in FY2024, slight decrease due to inventory and deposits
- • Cash used in investing $1.4M in FY2025 for software and app development vs $2.2M in FY2024 for leasehold improvements
- • Cash used in financing $7.6M in FY2025 for stock repurchases, dividends, and tax withholding vs $14.4M in FY2024
- • Working capital $23.7M at June 30, 2025 vs $15.3M at June 30, 2024, driven by higher cash, inventory, and prepaid expenses
- • No outstanding balance on 2024 Credit Facility as of June 30, 2025; line of credit up to $5.0M available
- • Management expects current cash flow and reserves sufficient for next 12 months; may adjust capital spending or seek additional funding if needed
Risk Factors
- • Cybersecurity risk oversight by audit committee with direct board reporting on material incidents and financial effects
- • CIIO with 40+ years IT security experience leads cybersecurity program addressing risk detection and mitigation
- • Potential operational disruption from cybersecurity threats managed via continuous monitoring and remediation efforts
Lifevantage Corp FY2025 Key Financial MetricsXBRL
Revenue
$229M
▲ +14.2% YoY
Net Income
$10M
▲ +233.8% YoY
Gross Margin
80.4%
▲ +107bp YoY
Operating Margin
5.3%
▲ +317bp YoY
Net Margin
4.3%
▲ +282bp YoY
ROE
28.3%
▲ +1700bp YoY
Total Assets
$72M
▲ +19.3% YoY
EPS (Diluted)
$0.75
▲ +226.1% YoY
Operating Cash Flow
$12M
▼ -2.6% YoY
Source: XBRL data from Lifevantage Corp FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on Lifevantage Corp
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.